c-rel activates but v-rel suppresses transcription from kappa B sites.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 2023921.
- Also identified by PMC identifier 51523.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We show that the product of the protooncogene c-rel is a constituent of an NF-kappa B-like complex that binds to the kappa B site originally identified in the enhancer of immunoglobulin kappa light chain gene. c-rel protein synthesized in bacteria binds to the kappa B site in a sequence-specific manner. The rel-kappa B complex can be disrupted by incubation with anti-rel antibodies. The rel protein can form oligomers. The c-rel protein can activate transcription from promoters containing kappa B sites; v-rel, on the other hand, suppresses the transcription of genes linked to kappa B sites. Thus, v-rel may interfere with the normal transcriptional machinery of the cell by acting as a dominant negative mutant.
Medical subject headings
- Gene Expression Regulation
- NF-kappa B
- Proto-Oncogene Proteins
- Retroviridae Proteins, Oncogenic